,drug_name,section_name,gpt_output
0,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, muscle disorder, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity"
1,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
2,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, concomitant neuromuscular disorders, exacerbate clinical effects, smaller neck muscle mass, bilateral injections into the sternocleidomastoid muscles, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, diplopia, ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, life threatening, death, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, swallowing difficulties, breathing difficulties, severe dysphagia, feeding tube, aspiration, respiratory failure, critical loss of breathing capacity, respiratory disorders, severe dysphagia, respiratory compromise, persistent epithelial defect, ectropion, VII nerve disorders, protective drops, ointment, therapeutic soft contact lenses, closure of the eye, patching, anticholinergic effects, narrow angle glaucoma, ecchymosis, gentle pressure at the injection site, levator palpebrae superioris, larger brow depressor complexes, corrugator injections, bony supraorbital ridge, human albumin, transmission of viral diseases, Creutzfeldt-Jakob disease (CJD)."
3,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
4,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, acute pain, increases in blood pressure, adverse cardiovascular effects"
5,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, Muscle discomfort, Dyspepsia, Upper respiratory tract infection, Urinary frequency, Nocturia, Fractures, Arrhythmia, Chest pain or chest discomfort, Cardiac failure, High Total Bilirubin, Pyrexia, Groin pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis."
6,ZYTIGA,warnings and precautions,"hypertension, hypokalemia, fluid retention, grade 3 to 4 hypertension, grade 3 to 4 hypokalemia, grade 3 to 4 edema, adrenocortical insufficiency, increases in liver enzymes, drug interruption, dose modification, discontinuation, hepatotoxicity, grade 3 or 4 ALT or AST increases, Treatment discontinuation due to liver enzyme increases, Elevations of AST, ALT, bilirubin"
7,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
8,TOVIAZ,warnings and precautions,"Angioedema of the face, lips, tongue, and/or larynx, urinary retention, severe constipation, narrow-angle glaucoma, headache, dizziness, somnolence"
9,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Bone Mineral Density decrease, bone fractures, Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, ALT abnormalities, alkaline phosphatase abnormalities, bilirubin abnormalities, serum glucose abnormalities, glycosuria, neutrophils abnormalities, fasting cholesterol abnormalities, fasting triglycerides abnormalities, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, rash, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia"
10,STRIBILD,boxed warnings,"Lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
11,STRIBILD,warnings and precautions,"acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, obesity, prolonged nucleoside exposure, hepatotoxicity, hepatomegaly, steatosis, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, proximal renal tubular dysfunction, bone pain, pain in extremities, fractures, muscular pain, weakness, decreased bone mineral density, increased bone turnover, higher serum parathyroid hormone levels, higher 1.25 Vitamin D levels, osteomalacia, arthralgias, muscle pain, hypophosphatemia, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, angioedema, urticaria, hypersensitivity, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, hyperphosphatemia"
13,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
14,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, dry mouth, diarrhea, vomiting, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
15,VICTRELIS,warnings and precautions,"birth defects, fetal death, anemia, decrease in hemoglobin concentrations, neutropenia, worsening of neutropenia, hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, pancytopenia"
16,VIMIZIM,adverse reactions,"Anaphylaxis and hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue"
17,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions"
18,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
19,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
20,BEPREVE,warnings and precautions,"contact lens-related irritation, contamination, eye is red"
21,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Decreased appetite, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Hyperhidrosis, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Lipids abnormalities, Proteinuria, Orthostatic hypotension, Stevens-Johnson syndrome."
22,PRISTIQ,boxed warnings,"SUICIDAL THOUGHTS AND BEHAVIORS, increased risk of suicidal thoughts and behavior in children, adolescents, and young adults, worsening, emergence of suicidal thoughts and behaviors"
23,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, suicidal ideation, suicidality, unusual changes in behavior, suicidal thinking, suicidal behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances (e.g., paresthesia, such as electric shock sensations), confusion, lethargy, emotional lability, tinnitus, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, progressive dyspnea, cough, chest discomfort."
24,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
25,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, cutaneous, New primary malignancies, non-cutaneous, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, major hemorrhages, symptomatic bleeding in a critical area or organ, intracranial hemorrhage, gastric hemorrhage, deep venous thrombosis (DVT), pulmonary embolism (PE), Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, fever, hypotension, rigors or chills, dehydration, renal failure, severe skin toxicity, secondary infections of the skin, hemolytic anemia."
26,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia and hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, QT prolongation, Diarrhea, Nausea, Abdominal pain, Vomiting, Dyspeptic signs and symptoms, Asthenic conditions, Bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, Photosensitivity reaction, dysgeusia, Early increases in creatinine >=10%, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease, pneumonitis, pulmonary fibrosis, Anaphylactic reactions, angioedema, Vasculitis, leukocytoclastic vasculitis"
27,MULTAQ,boxed warnings,"INCREASED RISK OF DEATH, STROKE, HEART FAILURE, doubles the risk of death, hospitalization for heart failure"
28,MULTAQ,warnings and precautions,"cardiovascular death, heart failure, increased risk of stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, hypokalemia, hypomagnesemia, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, small increases in creatinine levels"
29,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, Constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, documented symptomatic hypoglycemia, severe hypoglycemia, pneumonia, atrial fibrillation, atrial flutter, appendicitis, anti-albiglutide antibodies, anti-GLP-1 antibodies, antibodies to human albumin, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
30,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
31,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, acute pancreatitis, persistent severe abdominal pain, vomiting, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration"
32,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, infection, increased creatinine, multi-organ failure, hepatic failure, Grade 4 tumor lysis syndrome, ventricular fibrillation, febrile neutropenia"
33,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, Serious and fatal infections, pneumonia, sepsis, Hepatotoxicity, liver function test abnormalities, Tumor lysis syndrome, Nausea, vomiting, diarrhea, fetal harm, teratogenicity, embryo-fetal lethality"
34,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
35,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation, Severe neutropenia, Grade 4 neutropenia, febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, Neuropathy lasting more than one year, new or worsening neuropathy, Embryo-fetal toxicity, teratogenicity, QT prolongation, congestive heart failure, bradyarrhythmias, hypokalemia, hypomagnesemia"
36,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, injection site swelling, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe penile hematoma, severe injection site hematoma, penile ""popping"" sounds or sensations."
37,XIAFLEX,boxed warnings,"corporal rupture (penile fracture), penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma"
38,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, possible permanent injury, tendon rupture, ligament damage, skin laceration, Corporal rupture (penile fracture), serious injury to the penis, possible permanent injury, corporal rupture (penile fracture), Hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, damage to structures, permanent injury, tendon rupture, ligament damage, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin laceration requiring skin graft, corporal rupture, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, Severe penile hematoma, damage to structures, injury, corporal rupture (penile fracture), mild allergic reactions (pruritus), severe allergic reactions, anaphylaxis, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis."
39,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
40,CIMZIA,boxed warnings,"serious infections, hospitalization, death, Active tuberculosis, reactivation of latent tuberculosis, disseminated tuberculosis, extrapulmonary tuberculosis, Invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated disease, Bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, sepsis, Lymphoma, malignancies, fatal malignancies"
41,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, worsening congestive heart failure (CHF), new onset CHF, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatosplenic T-cell lymphoma (HSTCL), acute and chronic leukemia, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, infection signs (e.g., persistent fever, bruising, bleeding, pallor), autoantibodies, lupus-like syndrome"
42,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
43,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome, anaphylaxis, hypotension, hypoalbuminemia, edema, hemoconcentration, Tumor Growth Stimulatory Effects on Malignant Cells"
44,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
45,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, swelling of the lips, tongue, or throat, urticaria, rash, itching, eye pain or discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination"
46,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, fatigue, asthenia, pyrexia, dizziness, urinary tract infection, dehydration, Gastritis, intestinal obstruction."
47,JEVTANA,boxed warnings,"neutropenic deaths, generalized rash/erythema, hypotension, bronchospasm"
48,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, fatal infectious adverse events, sepsis, septic shock, Grade 3-4 neutropenia, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, severe hypersensitivity reactions, nausea, vomiting, severe diarrhea, diarrhea related mortality, electrolyte imbalance, gastrointestinal hemorrhage, gastrointestinal perforation, ileus, enterocolitis, neutropenic enterocolitis, abdominal pain, tenderness, fever, persistent constipation, renal failure, obstructive uropathy, fetal harm, embryotoxic, fetotoxic, abortifacient."
49,ILARIS,adverse reactions,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, hypersensitivity reactions, decreased white blood cells, neutrophils, platelets, transient decreases in absolute neutrophil count, mild and transient decreases in platelet counts, elevations of transaminases, high ALT and/or AST, asymptomatic and mild elevations of serum bilirubin"
50,ILARIS,warnings and precautions,"increased risk of serious infections, infections, upper respiratory tract infections, serious upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, new tuberculosis, reactivation of latent tuberculosis, malignancies, hypersensitivity reactions, anaphylactic reactions, Macrophage Activation Syndrome (MAS)"
51,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events leading to discontinuation, confusional state"
52,AMPYRA,warnings and precautions,"seizures, anaphylaxis, respiratory compromise, urticaria, angioedema of the throat and or tongue, urinary tract infections"
53,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, alanine aminotransferase or aspartate aminotransferase greater than or equal to 3 times the upper limit of normal"
54,SIRTURO,boxed warnings,"INCREASED MORTALITY, QT PROLONGATION, significant ventricular arrhythmia, QTcF interval >500 ms"
55,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, increased risk of death, death, use with other QT prolonging drugs, history of Torsade de Pointes, history of congenital long QT syndrome, history of or ongoing hypothyroidism, history of or ongoing bradyarrhythmias, history of uncompensated heart failure, serum calcium levels below the lower limits of normal, serum magnesium levels below the lower limits of normal, serum potassium levels below the lower limits of normal, Clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks"
56,ADREVIEW,adverse reactions,"serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
57,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic and hypersensitivity treatment measures, serious reactions in premature or low birth-weight infants, withdrawal signs and symptoms, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation in the thyroid, unreliable imaging results, clinically significant withdrawal symptoms, ""Gasping Syndrome"", hypotension, metabolic acidosis, increased incidence of kernicterus, deaths in preterm infants, benzyl alcohol toxicity, decreased cardiac uptake of AdreView, increased long term risk for thyroid neoplasia, transient episode of hypertension"
58,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, cough post-inhalation, respiratory-related deaths, asthma exacerbation, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
59,ARCAPTA,boxed warnings,asthma-related death
60,ARCAPTA,warnings and precautions,"clinically significant cardiovascular effects, fatal, Immediate hypersensitivity reactions, Life-threatening paradoxical bronchospasm, increase in asthma-related deaths, Serious asthma-related events, death, exacerbation rates, overdose, difficulties in breathing, swallowing, swelling of tongue, lips and face, urticaria, skin rash, paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, symptoms, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, aggravate pre-existing diabetes mellitus, ketoacidosis, significant hypokalemia, adverse cardiovascular effects, increases in plasma glucose"
61,INTELENCE,adverse reactions,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, Severe hypersensitivity reactions including DRESS, rhabdomyolysis, Fatal cases of toxic epidermal necrolysis"
62,INTELENCE,warnings and precautions,"Severe skin reactions, potentially life threatening skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rashes, Grade 4 rashes, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
63,PICATO,adverse reactions,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, Application Site Pain, Application Site Pruritus, Application Site Infection, Periorbital Edema, Headache, Application Site Pruritus, Application Site Irritation, Nasopharyngitis, Application Site Pain, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
64,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, severe reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
65,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure"
66,VIZAMYL,warnings and precautions,"Hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, increased risk of cancer, motion artifacts"
67,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Asthenia, Influenza, Weight increased, Tremor, Vertigo, Abnormal coordination, Disturbance in attention, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Paresthesia, Amnesia, Dysphasia, Confusional state, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention, malaise, increased liver enzymes, weight gain, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
68,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, damage to the photoreceptors, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
69,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, potential vision loss, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, urinary hesitation, dysuria, hydronephrosis, renal function impairment, skin abnormalities, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, nail discoloration, lip discoloration, mucous membrane discoloration, palate discoloration, sclera discoloration, conjunctiva discoloration, withdrawal seizures"
70,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
71,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, increased risk of asthma-related hospitalization in pediatric and adolescent patients"
72,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, acutely deteriorating COPD, acute symptoms, overdose, Candida albicans infection, pneumonia, worsening of infections, existing tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction in children and adolescents"
73,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, injection site pruritus, injection site warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
74,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury"
75,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, Hypersensitivity, Anaphylactoid/anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, NSF, circulatory collapse, Acute Kidney Injury requiring dialysis, tissue irritation"
76,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
77,NESINA,warnings and precautions,"acute pancreatitis, anaphylaxis, angioedema, severe cutaneous adverse reactions, hepatic failure, hypoglycemia, severe and disabling arthralgia, Stevens-Johnson syndrome, serum alanine aminotransferase (ALT) elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
78,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis"
79,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death"
80,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, elevations of hepatic transaminases, transient increase in mean eosinophil counts"
81,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, progressive multifocal leukoencephalopathy (PML), death, severe disability, opportunistic viral infection, brain infection, JC virus (JCV), immunocompromised, prolonged lymphopenia, lymphocyte counts <0.5x10^9/L, progressive weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation, confusion, personality changes, decrease in lymphocyte counts, infections, serious infections, flushing, warmth, redness, itching, burning sensation, hospitalization"
82,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis and Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, Nasopharyngitis, Infection, Herpes simplex, Hyperuricemia, Pruritus, Hemoglobin Decreased, Platelets Decreased, Leukocytes Decreased, Lymphocytes Decreased, Neutrophils Decreased, bilirubin elevations, increased bilirubin, increases in AST, increases in ALT, creatinine levels changes, Tachycardia, Constipation, Stomatitis, Abdominal pain, Dyspepsia, Gastroesophageal reflux disease, Abdominal pain upper, Abdominal distension, Chills, Edema peripheral, Chest pain, Infusion site pain, Pain, Catheter site pain, Herpes zoster, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Pneumonia, Febrile neutropenia, Oral candidiasis, Weight decreased, Dehydration, Decreased appetite, Hypokalemia, Back pain, Arthralgia, Pain in extremity, Bone pain, Headache, Dizziness, Dysgeusia, Insomnia, Anxiety, Depression, Pharyngolaryngeal pain, Wheezing, Nasal congestion, Dry skin, Night sweats, Hyperhidrosis, Hypotension, hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia/taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN)."
83,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, signs of infection, Anaphylaxis, Infusion Reactions, severe anaphylactic reactions, Tumor Lysis Syndrome, Acute renal failure, Skin Reactions, severe skin reactions, SJS, TEN, Other Malignancies, pre-malignant diseases, malignant diseases, Extravasation, erythema, swelling, pain, Embryo-fetal toxicity, fetal harm, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights, neutropenic sepsis, diffuse alveolar hemorrhage, Grade 3 thrombocytopenia, pneumonia, opportunistic infection, CMV, leukocytes, platelets, hemoglobin, neutrophils, dose delays, dose reductions, ANC, platelet count, pneumonia, sepsis, septic shock, fever, chills, pruritus, rash, anaphylactoid reactions, allergic-type reactions, blood chemistry, potassium levels, uric acid levels, rash, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis, Stevens-Johnson syndrome, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasations, hospitalizations, redness, infection, necrosis, resorptions, skeletal and visceral malformations, decreased fetal body weights"
84,ELIQUIS,adverse reactions,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, bleeding-related adverse reactions, Major bleeding, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial bleeding, Non-intracranial bleeding, Hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, Gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
85,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis"
86,ELIQUIS,warnings and precautions,"serious, potentially fatal bleeding, increased risk of thrombotic events, increased rate of stroke, risk of bleeding, signs and symptoms of blood loss, active pathological hemorrhage, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, numbness or weakness of the legs, bowel, or bladder dysfunction"
87,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low) less than 50*10^9/L, Absolute Neutrophil Count less than 1*10^9/L, Hemoglobin (Low) less than 80 g/L, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low) less than 0.6 mmol/L, Total Bilirubin greater than 3.0*ULN, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption."
88,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, nausea, vomiting, abdominal pain, Myelosuppression, Thrombocytopenia, anemia, neutropenia, Hepatic Toxicity, drug induced liver injury, ALT elevation, AST elevation, Fluid Retention, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, severe fluid retention, Grade 3 or 4 pleural effusion, Grade 3 or Grade 4 pericardial effusions, Grade 3 peripheral and pulmonary edema, Grade 3 edema, Renal Toxicity, decline in estimated glomerular filtration rate (eGFR), Embryofetal Toxicity, fetal harm"
89,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
90,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction delays, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Blood pressure increase, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, Varicella Zoster Virus, blurred vision, decreased visual acuity, visual disturbances, sudden onset of severe headache, altered mental status, seizure, ischemic stroke, cerebral hemorrhage, forced expiratory volume over 1 second (FEV1) reduction, diffusion lung capacity for carbon monoxide (DLCO) reduction, dyspnea, elevation of liver transaminases, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, hypertension, lymphocyte counts decrease."
91,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, mild infusion reactions of nausea, erythematous rash, pruritus, eyelid edema, headache, dyspnea, Fatal anaphylaxis"
92,BENLYSTA,warnings and precautions,"deaths, Serious Infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), neurological deficits, fatal cases, Hypersensitivity Reactions, Anaphylaxis, death, Depression, suicidality, suicidal thoughts, mood changes, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, Malignancy, non-melanoma skin cancers, rash, nausea, fatigue, myalgia, headache, facial edema, hypotension, angioedema, urticaria, pruritus, dyspnea, Infusion Reactions, bradycardia, skin reactions, insomnia, anxiety, psychiatric events"
93,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, hepatotoxicity, ILD, Electrocardiogram QT prolonged, Bradycardia, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Upper respiratory infection, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Dysgeusia, Headache, fatigue, neuropathy, rash, renal cyst, ILD, syncope, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, dyspnea, pneumonia, pneumonitis, pulmonary embolism, ILD, respiratory failure, sepsis, alanine aminotransferase (ALT) elevation, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, Dizziness, Dysgeusia, Syncope, Vision disorder, Electrocardiogram QT prolonged, Bradycardia, Weight decreased, Vomiting, Nausea, Diarrhea, Constipation, Dyspepsia, Upper respiratory infection, Pulmonary embolism, Edema, fatigue, neuropathy, dysesthesia, gait disturbance, hypoesthesia, muscular weakness, neuralgia, peripheral neuropathy, parasthesia, peripheral sensory neuropathy, polyneuropathy, burning sensation in skin, rash, ILD, acute respiratory distress syndrome, ILD, pneumonitis, renal cyst, hepatic failure, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypokalemia, Hypophosphatemia, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy."
94,XALKORI,warnings and precautions,"Fatal hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, Concurrent elevations in alanine aminotransferase (ALT) or aspartate aminotransferase (AST), elevations in ALT or AST greater than five times the ULN, permanent discontinuation due to elevated transaminases, Severe, life-threatening, or fatal interstitial lung disease (ILD)/pneumonitis, Grade 3 or 4 ILD, fatal ILD, QTcF greater than or equal to 500 ms, increase from baseline QTcF greater than or equal to 60 ms, Torsade de pointes, polymorphic ventricular tachycardia, signs/symptoms of serious arrhythmia, symptomatic bradycardia, heart rate less than 50 beats per minute, Grade 3 syncope, Grade 4 visual field defect with vision loss, Optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity."
95,CLEVIPREX,adverse reactions,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation (possible pulmonary shunting), reflex tachycardia"
96,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
97,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, flu-like illness, chills, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
98,LUMIZYME,boxed warnings,"anaphylactic reactions, severe hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload"
99,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated cutaneous reactions, necrotizing skin lesions, systemic immune-mediated reactions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, sudden cardiac death, immunogenicity, reduced clinical efficacy, loss of motor function, ventilator dependence, IgG antibody formation, inhibitory antibody activity, IgE antibodies"
100,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
101,CERDELGA,warnings and precautions,"prolongation of the PR, QTc, and/or QRS cardiac intervals, cardiac arrhythmias, congestive heart failure, recent acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
102,NEURACEQ,adverse reactions,"injection site reaction consisting of erythema (1.7 %), irritation (1.2 %), pain (3.9 %)"
103,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, increased risk of cancer, unintentional radiation exposure"
104,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Bone pain, Myalgia, Spinal osteoarthritis, Sciatica, Insomnia, Rash, Pruritus, Pancreatitis, New Malignancies, cataracts, Drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe cases of musculoskeletal pain, Marked elevation in serum PTH"
105,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, hospitalization, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, disturbances of mineral metabolism, marked elevations of serum parathyroid hormone (PTH), infections of the abdomen, urinary tract infections, ear infections, endocarditis, opportunistic infections."
106,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
107,FANAPT,boxed warnings,"increased risk of death, cardiovascular (e.g., heart failure, sudden death), infectious (e.g., pneumonia)"
108,FANAPT,warnings and precautions,"increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular/cerebrovascular risk, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, hyperpyrexia, muscle rigidity, altered mental status, catatonic signs, autonomic instability, irregular pulse, blood pressure, diaphoresis, cardiac dysrhythmia, creatine phosphokinase elevation, myoglobinuria, rhabdomyolysis, acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, involuntary dyskinetic movements, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, body temperature regulation disruption, Dysphagia, esophageal dysmotility, aspiration pneumonia, somnolence, sedation."
109,FULYZAQ,adverse reactions,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
110,FULYZAQ,warnings and precautions,disease may worsen
111,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
112,EOVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury"
113,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions including shock, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, rapid decrease in kidney function, hypersensitivity reactions, anaphylactic reactions, shock, reactions to contrast media, bronchial asthma, allergic disorders, acute kidney injury requiring dialysis, local tissue reactions, myocyte necrosis and inflammation, falsely high or low serum iron values, severe renal or hepatic failure, elevated serum ferritin levels, reduced hepatic contrast, abnormally high serum bilirubin"
114,ONFI,adverse reactions,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, constipation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, Vomiting, Constipation, Dysphagia, Pyrexia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence, Sedation, Lethargy, Drooling, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, Aspiration, respiratory depression, Rash, urticaria, angioedema, facial and lip edema"
115,ONFI,warnings and precautions,"Somnolence or Sedation, central nervous system (CNS) depression, Withdrawal Symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, Physical and Psychological Dependence, habituation and dependence, Suicidal Behavior and Ideation, suicidal thoughts or behaviors, depression, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, rash, seizure exacerbation, status epilepticus, mood changes, self-harm"
116,COMETRIQ,adverse reactions,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, general deterioration, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia."
117,COMETRIQ,boxed warnings,"Gastrointestinal perforations, fistula formation, Severe hemorrhage, sometimes fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage"
118,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, serious arterial thromboembolic events, dehiscence, complications requiring medical intervention, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), fetal harm, Gastrointestinal (GI) perforations, fistulas, fatal GI fistula, Non-GI fistulas, tracheal/esophageal fistulas, fatal Non-GI fistulas, Serious hemorrhage, fatal hemorrhage, Grade >=3 hemorrhagic events, venous thromboembolism, arterial thromboembolism, acute myocardial infarction, clinically significant arterial thromboembolic complication, wound complications, treatment-emergent hypertension, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (modified JNC criteria) stage 1 or 2 hypertension, severe hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations."
119,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, proteinuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
120,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), central nervous system (CNS) involvement, increased susceptibility to infection, development of malignancies, graft loss, death"
121,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), increased risk, predominantly involving the CNS, new or worsening neurological, cognitive, or behavioral signs and symptoms, Other malignancies, increased risk, Progressive Multifocal Leukoencephalopathy (PML), increased risk, Other serious infections, increased risk of bacterial, viral, fungal, and protozoal infections, opportunistic infections, tuberculosis, Some infections were fatal, Polyoma virus-associated nephropathy, kidney graft loss, Liver transplant, use is not recommended, Acute Rejection and Graft Loss with Corticosteroid Minimization, increased rate and grade of acute rejection, particularly Grade III rejection, Graft loss, Immunizations, avoid use of live vaccines."
122,GILOTRIF,adverse reactions,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, Gastrointestinal disorders, Stomatitis, Cheilitis, Skin and subcutaneous tissue disorders, Infections and infestations, Cystitis, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Epistaxis, Rhinorrhea, Investigations, Weight Decreased, General disorders and administration site conditions, Pyrexia, Eye disorders, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis"
123,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, severe and prolonged diarrhea, Bullous and Exfoliative Skin Disorders, severe bullous, blistering, exfoliating lesions, life-threatening cutaneous reactions, Interstitial lung disease (ILD), acute onset or worsening of pulmonary symptoms, Hepatic toxicity, Fatal hepatic impairment, Keratitis, ulcerative keratitis, Embryofetal toxicity, fetal harm, dehydration with or without renal impairment, fatal cases, Grade 3 diarrhea, Renal impairment, Grade 3 cutaneous reactions, rash, erythema, acneiform rash, Grade 1-3 palmar-plantar erythrodysesthesia syndrome, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, abortions at late gestational stages."
124,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
125,DATSCAN,warnings and precautions,"Hypersensitivity reactions, skin erythema, pruritis, anaphylactic, thyroid neoplasia"
126,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, local pruritus, erythema, pain, irritation, urticaria, bruising, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
127,KALBITOR,boxed warnings,"Anaphylaxis, hypersensitivity reactions"
128,KALBITOR,warnings and precautions,"anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
129,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, Ear and labyrinth disorders, Vertigo, Eye disorders, Diplopia, Blurred vision, Visual impairment, Gastrointestinal disorders, Nausea, Vomiting, Diarrhea, Constipation, Abdominal pain, Gastritis, General disorders and administration site conditions, Fatigue, Asthenia, Gait disturbance, Peripheral edema, Infections and Infestations, Urinary tract infections, Injury, poisoning and procedural complications, Fall, Metabolism and nutrition disorders, Hyponatremia, Nervous system disorders, Dizziness, Somnolence, Headache, Ataxia, Balance disorder, Tremor, Dysarthria, Memory impairment, Nystagmus, Psychiatric disorders, Depression, Insomnia, Respiratory, thoracic and mediastinal disorders, Cough, Skin and subcutaneous tissue disorders, Rash, Vascular disorders, Hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase"
130,APTIOM,warnings and precautions,"Suicidal thoughts or behavior, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, increased seizure frequency, status epilepticus, Drug Induced Liver Injury, abnormal thyroid function tests, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, diplopia, blurred vision, impaired vision, mild to moderate elevations in transaminases, elevated bilirubin"
131,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism (deep venous thrombosis, pulmonary embolism, retinal vein thrombosis)"
132,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, increased risk of endometrial hyperplasia, stroke, deep vein thrombosis (DVT), unusual vaginal bleeding, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma, worsening of diabetes, worsening of epilepsy, migraines, genetic problem called porphyria, lupus, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, nauseavomitingbreast tendernessdizzinessabdominal painfeeling tiredvaginal bleeding"
133,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, probable dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, pancreatitis, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
134,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
135,KALYDECO,warnings and precautions,"Elevated transaminases (ALT or AST), increased transaminase levels, non-congenital lens opacities/cataracts"
136,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
137,AMYVID,warnings and precautions,"Image interpretation errors, false negatives, Radiation risk, increased risk of cancer, unintentional radiation exposure"
138,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, adverse events leading to discontinuation, Insomnia, Depression, Abnormal dreams, Dizziness, Headache, Nausea, Diarrhea, Rash, Fatigue, Vertigo, Grade 1 insomnia, Abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, Hepatitis, Myositis, Suicidal ideation, attempt, behavior, or completion, Renal impairment, Pruritus, ALT abnormalities, AST abnormalities, Creatine kinase abnormalities, Hyperglycemia, Lipase abnormalities, Total neutrophils abnormalities, Cholesterol changes, HDL cholesterol changes, LDL cholesterol changes, Triglycerides changes, elevated ALT, elevated AST, elevated cholesterol, elevated creatine kinase, hyperglycemia, elevated lipase, Grade 3 to 4 treatment-emergent hematology laboratory abnormality, neutropenia, Grades 2 to 4 ALT abnormalities, Liver chemistry elevations consistent with immune reconstitution syndrome, Increases in serum creatinine, Grade 2 ADRs, rash, abdominal pain, diarrhea, Grade 3 laboratory abnormalities, elevated total bilirubin, elevated lipase, changes in mean serum creatinine."
139,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, signs or symptoms of hypersensitivity reactions, severe rash, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters or peeling of the skin, oral blisters or lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, difficulty breathing, life-threatening reaction, worsening or development of transaminase elevations, hepatotoxicity, immune reconstitution syndrome, hepatitis B reactivation, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
140,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, Pain, Pruritus, Erythema, Pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
141,ULESFIA,warnings and precautions,"gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis"
142,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
143,TRULICITY,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, systemic hypersensitivity adverse reactions, injection-site reactions, PR Interval Prolongation, first degree Atrioventricular (AV) Block, Amylase and Lipase Increase"
144,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
145,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease"
146,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, Serious Adverse Reactions, Adverse Reactions Leading to Discontinuation, Diarrhea, Nausea, Constipation, Vomiting, Increased transaminases, Hypokalemia, Rash, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis"
147,TEFLARO,warnings and precautions,"Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), Direct Coombs' test seroconversion, mild diarrhea, fatal colitis, increased morbidity, mortality, refractory to antimicrobial therapy, colectomy, drug-induced hemolytic anemia, development of drug-resistant bacteria"
148,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Thirst (including polydipsia), Volume Depletion (e.g., blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolemia, orthostatic hypotension, syncope), Increased Urination (e.g., polyuria, pollakiuria, nocturia), Impairment in Renal Function (increases in serum creatinine and decreases in eGFR), Hypoglycemia, Genital Mycotic Infections (e.g., vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis), Phimosis, Urinary Tract Infections (e.g., urinary tract infection, asymptomatic bacteriuria, cystitis), Increase in Low-Density Lipoprotein Cholesterol (LDL-C), Increase in Hematocrit."
149,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
150,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions."
151,ULORIC,warnings and precautions,"gout flares, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, fatal hepatic failure, non-fatal hepatic failure, transaminase elevations, AST elevations, ALT elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, abnormal liver tests, drug-induced liver injury"
152,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, myocardial infarction, upper respiratory tract infection, constipation, peripheral neuropathies NEC, insomnia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, embolic and thrombotic events, venous, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, tumor lysis syndrome, posterior reversible encephalopathy syndrome"
153,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction with fatal outcome, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome (TLS), Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension including hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), Posterior reversible encephalopathy syndrome (PRES), Embryo-fetal Toxicity, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, renal impairment, renal failure, pneumonitis, interstitial lung disease, pulmonary arterial hypertension, deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, increased serum transaminases, seizure, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances"
154,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, Diarrhea, Colitis, Pruritus, Rash, Fatigue, Enterocolitis, Hepatotoxicity, Dermatitis, Neuropathy, Endocrinopathy, Hypopituitarism, Adrenal insufficiency, Pneumonitis, Meningitis, Nephritis, Eosinophilia, Pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
155,YERVOY,boxed warnings,"severe and fatal immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
156,YERVOY,warnings and precautions,"severe and fatal immune-mediated reactions, severe immune-mediated enterocolitis, life-threatening immune-mediated enterocolitis, fatal immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, moderate immune-mediated enterocolitis, abdominal pain, mucus or blood in stool, intestinal perforation, complications, severe enterocolitis, hospitalization, immune-mediated hepatitis, hepatotoxicity, AST or ALT elevations, total bilirubin elevations, fatal hepatic failure, liver function test abnormalities, immune-mediated endocrinopathies, thyroid function tests, signs and symptoms of endocrinopathy, hormone replacement therapy, severe immune-mediated dermatitis, life-threatening immune-mediated dermatitis, fatal immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic, bullous, or hemorrhagic manifestations, moderate immune-mediated dermatitis, pruritus, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, motor or sensory neuropathy, weakness, sensory alterations, paresthesia, severe neuropathy, moderate neuropathy, severe to life-threatening immune-mediated endocrinopathies, hospitalization, urgent medical intervention, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, hypophysitis, adrenal crisis, hyperthyroidism, hypothyroidism, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, immune-mediated ocular disease, corticosteroid eye drops, uveitis, iritis, episcleritis."
157,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
158,GADAVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury"
159,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, hypersensitivity reactions with cardiovascular manifestations, hypersensitivity reactions with respiratory manifestations, hypersensitivity reactions with cutaneous manifestations, death from hypersensitivity reactions, fatal or debilitating fibrosis affecting the skin, fatal or debilitating fibrosis affecting the muscle, fatal or debilitating fibrosis affecting internal organs, acute kidney injury, drug-induced kidney toxicity, NSF with chronic, severe kidney disease, NSF with acute kidney injury, NSF with chronic, moderate kidney disease, NSF with chronic, mild kidney disease, Extravasation, moderate irritation, Overestimation of Extent of Malignant Disease in MRI of the Breast"
160,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, tension headache, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
161,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, weight loss, loss of efficacy, reduction of systemic exposure of apremilast, suicidal ideation, suicidal behavior, attempted suicide, serious depression"
162,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, breathing difficulties, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, dysphagia, gait disturbance, hypertonia, sensation of heaviness, immunogenicity, antibodies (binding or neutralizing)."
163,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, swallowing difficulties, death"
164,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbate clinical effects of treatment, risk for transmission of Creutzfeldt-Jakob disease, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death related to spread of toxin effects, severe dysphagia, use of a feeding tube, aspiration, weaken neck muscles, critical loss of breathing capacity, respiratory failure, surgical alterations to the facial anatomy, excessive weakness, atrophy in the target muscle(s), marked facial asymmetry, inflammation at the injection site(s), excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, increased incidence of eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia, respiratory compromise, transmission of viral diseases, immune reaction when injected intradermally"
165,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
166,FIRAZYR,warnings and precautions,Laryngeal attacks
167,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), hypersensitivity-related adverse reactions (including erythema, rash, pruritus, urticaria, and angioedema), photosensitivity-related adverse reactions (including photosensitivity reaction, polymorphic light eruption, and sunburn), Volume Depletion-Related Adverse Reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, and dehydration), falls, serum creatinine increase, estimated GFR fall, renal-related adverse reactions (e.g., increased blood creatinine, decreased glomerular filtration rate, renal impairment, and acute renal failure), genital mycotic infections (e.g., vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis), phimosis, hypoglycemia, severe hypoglycemia, bone fractures, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in LDL-C and non-HDL-C, increases in hemoglobin, decreases in Bone Mineral Density (BMD)."
168,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
169,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis, falls and fall-related injuries, hypertensive crisis"
170,XTANDI,warnings and precautions,"Seizure, seizure occurred from 31 to 603 days after initiation of XTANDI, Patients experiencing seizure were permanently discontinued from therapy, all seizure events resolved, history of seizure, underlying brain injury with loss of consciousness, transient ischemic attack within the past 12 months, cerebral vascular accident, brain metastases, brain arteriovenous malformation, risk of seizure associated with XTANDI use, sudden loss of consciousness."
171,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, hyperglycemia, anemia, decreased potassium, increased AST, increased ALT, thrombocytopenia, hyperglycemia, dyspnea, pneumonitis, diarrhea, hypercholesterolemia, hypertriglyceridemia, increased creatinine, acute renal failure, acute respiratory distress, cardiac arrest, death (cause unknown), hepatic failure, pneumonia, sepsis, pulmonary embolism, hypoglycemia, myocardial infarction with congestive heart failure, sudden death, renal failure, thrombosis, pulmonary embolus, stomatitis, abdominal pain, nausea, vomiting, constipation, dry mouth, fatigue/malaise, edema (general and peripheral), fever, asthenia, nasopharyngitis/rhinitis/URI, urinary tract infection, weight decreased, diabetes mellitus, arthralgia, back pain, pain in extremity, muscle spasms, headache/migraine, dysgeusia, dizziness, insomnia, cough/productive cough, epistaxis, dyspnea/dyspnea exertional, pneumonitis, oropharyngeal pain, rash, nail disorders, pruritus/pruritus generalized, dry skin/xeroderma, hypertension, hemoglobin decreased, lymphocytes decreased, platelets decreased, WBC decreased, neutrophils decreased, alkaline phosphatase increased, glucose (fasting) increased, cholesterol increased, bicarbonate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, creatinine increased, sodium decreased, albumin decreased, bilirubin increased, potassium increased, stomatitis, infections, asthenia, fatigue, cough, diarrhea, dyspnea, dehydration, pneumonitis, abdominal pain, asthenia, anemia, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, lymphopenia, hypophosphatemia, hypercholesterolemia, acute respiratory failure, infection, acute renal failure, stomatitis, diarrhea, nausea, vomiting, edema peripheral, pyrexia, mucosal inflammation, rash, pruritus, dry skin, anorexia, headache, dysgeusia, pain in extremity, abdominal pain, dry mouth, hemorrhoids, dysphagia, impaired wound healing, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, hemoglobin decreased, lymphocytes decreased, platelets decreased, neutrophils decreased, cholesterol increased, triglycerides increased, glucose increased, creatinine increased, phosphate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, bilirubin increased, stomatitis, amenorrhea, hypercholesterolemia, hypertriglyceridemia, anemia, hypophosphatemia, alkaline phosphatase increased, elevated aspartate transaminase (AST), elevated alanine transaminase (ALT), fasting hyperglycemia, stomatitis, respiratory tract infection, pyrexia, pneumonia, gastroenteritis, aggression, agitation, amenorrhea, elevated partial thromboplastin time, neutropenia, hypercholesterolemia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
172,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal outcome, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, surgical intervention, laboratory test alterations, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, vaccinations, live vaccines, embryo-fetal toxicity, fetal harm, pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus, sepsis, respiratory failure, hepatic failure, opportunistic infections, hypoxia, pleural effusion, cough, dyspnea, pneumocystis jiroveci pneumonia (PJP), swelling of the airways or tongue, respiratory impairment, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets, drug-drug interactions, hepatic impairment, severe hepatic impairment, mild hepatic impairment, moderate hepatic impairment, therapeutic drug monitoring, live virus vaccinations, intranasal influenza, measles, mumps, rubella, oral polio, BCG, yellow fever, varicella, TY21a typhoid vaccines, American Council on Immunization Practices (ACIP) guidelines, highly effective contraception."
173,ENTEREG,adverse reactions,"dyspepsia (ENTEREG, 1.5%; placebo, 0.8%)"
174,ENTEREG,boxed warnings,myocardial infarction with long-term use
175,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions in patients with severe hepatic impairment, serious adverse reactions in patients with complete gastrointestinal obstruction, serious adverse reactions in pancreatic and gastric anastomoses"
176,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, Aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
177,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, decreased exposure to lumefantrine, decreased efficacy, decreased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, potentiate QT prolongation, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence, severe hepatic and/or renal impairment"
178,DALVANCE,adverse reactions,"nausea (5.5%), headache (4.7%), diarrhea (4.4%), vomiting (2.8%), rash (2.7%), pruritus (2.1%), anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
179,DALVANCE,warnings and precautions,"Serious hypersensitivity (anaphylactic) and skin reactions, Rapid intravenous infusion of glycopeptide antibacterial agents can cause reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, abnormalities in liver tests (ALT, AST, bilirubin), mild diarrhea to fatal colitis, increased morbidity and mortality, refractory to antibacterial therapy, may require colectomy, development of drug-resistant bacteria"
180,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
181,FERRIPROX,boxed warnings,"agranulocytosis, serious infections, death, neutropenia, infection"
182,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, increased ALT values, increased AST values, decreased plasma zinc concentrations"
183,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, decrease in hemoglobin of >=2 g/dL, transfusion of >=2 units of packed red blood cells, bleeding at a critical site, fatal outcome, intracranial hemorrhage, intracerebral hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleeds, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleed, intraspinal bleed, intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, bleeding causing a fall in hemoglobin level of 2.0 g/dL, transfusion of 2 or more units of whole blood or red cells, clinical myocardial infarction, esophageal ulcer, angioedema, thrombocytopenia"
184,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment"
185,PRADAXA,warnings and precautions,"serious and fatal bleeding, thrombotic events, blood loss, hypotension, active pathological bleeding, bleeding, thrombocytopenia, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, midline back pain, sensory and motor deficits, numbness, tingling, weakness in lower limbs, bowel and/or bladder dysfunction, spinal cord decompression, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions"
186,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
187,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions"
188,HORIZANT,adverse reactions,"Somnolence/sedation, dizziness, RLS, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase"
189,HORIZANT,warnings and precautions,"Driving impairment, Somnolence/sedation, Dizziness, Suicidal thoughts or behaviors, Fatigue/asthenia, Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Withdrawal seizure, Pancreatic acinar cell adenoma and carcinoma, New tumors, Preexisting tumors worsened"
190,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, change in color vision, Non-arteritic anterior ischemic optic neuropathy (NAION)"
191,STENDRA,warnings and precautions,"hypotension, erection lasts greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, tinnitus, dizziness, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, resting hypotension, hypertension, unstable angina, angina with sexual intercourse, congestive heart failure, transient decreases in sitting blood pressure, priapism, penile tissue damage, permanent loss of potency, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, priapism, sickle cell anemia, multiple myeloma, leukemia, non-arteritic anterior ischemic optic neuropathy (NAION), decreased vision, permanent loss of vision, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
192,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Severe Renal Impairment, Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, anaphylaxis, infusion-related reactions, non-infectious pulmonary toxicity, serious adverse reactions, pneumonia, septic shock, supraventricular arrhythmia, urinary tract infection, PML, Stevens-Johnson syndrome, tumor lysis syndrome, hepatotoxicity, peripheral sensory neuropathy, acute respiratory distress syndrome, paraesthesia, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis"
193,ADCETRIS,boxed warnings,"PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML), death"
194,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathic pain, weakness, anaphylaxis, infusion reactions, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, hepatocellular injury, elevations of transaminases, elevations of bilirubin, progressive multifocal leukoencephalopathy (PML), pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations"
195,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, increased mortality, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, renal impairment, renal failure, dyspnea, urticaria, venous thrombosis"
196,ZERBAXA,warnings and precautions,"Decreased efficacy in patients with baseline CrCl of 30 to <=50 mL/min, Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis"
197,ZYDELIG,adverse reactions,"Hepatotoxicity, Severe Diarrhea or Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, sepsis, febrile neutropenia, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
198,ZYDELIG,boxed warnings,"FATAL AND SERIOUS TOXICITIES: HEPATIC, SEVERE DIARRHEA, COLITIS, PNEUMONITIS, INTESTINAL PERFORATION, Fatal and/or serious hepatotoxicity, Fatal and/or serious and severe diarrhea, Fatal and serious pneumonitis, Fatal and serious intestinal perforation"
199,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, elevations in ALT or AST, diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, treatment-emergent Grade 3 or 4 neutropenia, teratogenic effects in rats"
200,SIMPONI,adverse reactions,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, ALT elevations, autoimmune disorders, autoantibodies, infusion reaction, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, Upper respiratory tract infection, Viral infections, Bacterial infections, Bronchitis, Vascular disorders, Hypertension, Skin and subcutaneous disorders, Rash, General disorders and administration site conditions, Pyrexia, Blood and lymphatic disorders, Leukopenia, Superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Nervous system disorders, Dizziness, paresthesia, Gastrointestinal disorders, Constipation, Melanoma, Serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, Interstitial lung disease, Skin exfoliation, bullous skin reactions."
201,SIMPONI,boxed warnings,"serious infections leading to hospitalization or death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, serious infection, sepsis, latent TB, active TB, reactivation of latent tuberculosis, disseminated or extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated disease, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, signs and symptoms of infection, tuberculosis in patients who tested negative for latent tuberculosis infection, lymphoma, malignancies, some fatal"
202,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, Malignancies, Heart failure, Demyelinating disease, Hypersensitivity reactions, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, reactivation of tuberculosis, new tuberculosis infections, Hepatitis B Virus Reactivation, Malignancies in Pediatric Patients, lymphomas, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Malignancies in Adult Patients, lymphoma, non-melanoma skin cancer (NMSC), acute and chronic leukemia, hepatosplenic T-cell lymphoma (HSTCL), Melanoma, Merkel cell carcinoma, Congestive Heart Failure, worsening congestive heart failure (CHF), new onset CHF, Demyelinating Disorders, central nervous system (CNS) demyelinating disorders, multiple sclerosis (MS), peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, Hematologic Cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, serious systemic hypersensitivity reactions, anaphylactic reaction"
203,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, Febrile neutropenia, Anemia, Neutropenia, Thrombocytopenia, Leukopenia, Nausea, Constipation, Diarrhea, Abdominal pain, Vomiting, Pyrexia, Peripheral edema, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Pneumonia, Sepsis, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypokalemia, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Headache, Tremor, Dizziness, Insomnia, Cough, Dyspnea, Rash, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
204,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), life-threatening, fatal, Neurological toxicities, severe, life-threatening, fatal"
205,BLINCYTO,warnings and precautions,"Infections, Effects on Ability to Drive and Use Machines, Preparation and Administration Errors, Cytokine Release Syndrome (CRS), Infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, febrile neutropenia, seizures, loss of consciousness, Elevated Liver Enzymes, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, Preparation and Administration Errors, underdose, overdose"
206,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea/ or vomiting, acne, mood changes, increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), headache (including migraines), weight increased, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (for example, abdominal pain), vulvovaginal candidiasis"
207,NATAZIA,boxed warnings,CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS
208,NATAZIA,warnings and precautions,"thrombotic event, jaundice, uncontrolled hypertension, hypertension with vascular disease, significant change in headaches, irregular bleeding, amenorrhea, decreased contraceptive efficacy, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, thromboembolic disease, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, loss of vision, proptosis, diplopia, papilledema, retinal vascular lesions, retinal vein thrombosis, cervical cancer, intraepithelial neoplasia, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, increased blood pressure, gallbladder disease, decreased glucose tolerance, adverse lipid changes, hypertriglyceridemia, pancreatitis, new headaches, recurrent headaches, persistent headaches, severe headaches, migraine, breakthrough bleeding, spotting, intracyclic bleeding, depression, changes in laboratory tests, hereditary angioedema, chloasma."
209,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
210,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, hypersensitivity reactions, rash pruritus, angioedema of the mouth, throat, and face, allergy to other macrolides, development of drug-resistant bacteria"
211,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high markedly abnormal platelet counts, high markedly abnormal WBC counts, rash, pruritus, angioedema"
212,EDARBI,boxed warnings,"FETAL TOXICITY, injury and death to the developing fetus"
213,EDARBI,warnings and precautions,"fetal renal function reduction, fetal and neonatal morbidity and death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
214,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, hyperuricemia, uric acid increased, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, stomatitis, dyspepsia, sinusitis, skin infections, chills, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, gastroesophageal reflux disease, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema"
215,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, Fatal bleeding events, Infections, fever, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), Cytopenias, neutropenia, thrombocytopenia, anemia, Atrial Fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, new onset dyspnea, Second Primary Malignancies, non-skin carcinomas, non-melanoma skin cancer, Tumor Lysis Syndrome, Embryo-Fetal Toxicity, fetal harm, malformations, reduced fetal weights."
216,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, eye irritation, headache, increased IOP, limbal hyperemia, anterior chamber flare, dry eye, iridocyclitis"
217,DUREZOL,warnings and precautions,"glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, posterior subcapsular cataract formation, delayed healing, increase the incidence of bleb formation, corneal or scleral perforations, suppress the host response, increase the hazard of secondary ocular infections, mask infection, enhance existing infection, prolong the course of viral infections, exacerbate the severity of viral infections, fungal infections of the cornea, persistent corneal ulceration"
218,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, Abdominal pain, Esophageal disorder, Rash, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased"
219,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, elevated transaminases, jaundice, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, ventricular tachyarrhythmias, Torsade de pointes, sudden death, Hyperglycemia, Bradycardia, sinus bradycardia, Pancreatitis, elevations of lipase, elevations of amylase, skeletal anomalies in rats and rabbits, fetal harm"
220,CHOLINE,adverse reactions,mild injection site reaction
221,CHOLINE,warnings and precautions,"Imaging errors, allergic reactions, anaphylaxis, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, increased risk for cancer"
222,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis and hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, hyperlipidemia, ketoacidosis, CNS events"
223,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe pancreatitis, hemorrhagic pancreatitis, Glucose intolerance, hyperglycemia, Thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III."
224,SAPHRIS,adverse reactions,"Use in Elderly Patients with Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions including oral ulcers, blisters, peeling/sloughing and inflammation, Orthostatic Hypotension, Syncope, and other Hemodynamic Effects, Leukopenia, Neutropenia, and Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, Constipation, Dry mouth, Salivary hypersecretion, Stomach discomfort, Vomiting, Irritability, Increased weight, Increased appetite, Extrapyramidal symptoms (excluding akathisia), Insomnia, Hypertension, Anxiety, Dyspepsia, Toothache, Arthralgia, Pain in extremity, Headache, Depression, Tachycardia, Glossodynia, Edema peripheral, Parkinsonism, Suicidal ideation, Anger, Dysmenorrhea, Oropharyngeal pain, Nasal congestion, Dyspnea, Rash, transient elevations in serum transaminases (primarily ALT), Transaminases, Prolactin, Creatine Kinase (CK), anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, Choking."
225,SAPHRIS,boxed warnings,INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
226,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, Dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive and Motor Impairment, Suicide, Hypersensitivity Reactions, hypotension, swollen tongue, dyspnea, wheezing, rash, Hyperprolactinemia, Galactorrhea, amenorrhea, gynecomastia, impotence, Body Temperature Regulation, Dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease"
227,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
228,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage"
229,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, hyperbilirubinemia, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, cytogenetic abnormalities, Thrombotic microangiopathy with acute renal failure."
230,PROMACTA,boxed warnings,hepatic decompensation
231,PROMACTA,warnings and precautions,"hepatotoxicity, liver function abnormalities, portal vein thrombosis, hepatic decompensation, ascites, encephalopathy, liver enzyme elevations, indirect hyperbilirubinemia, increased direct bilirubin, clinical symptoms of liver injury, thrombotic event, thromboembolic complications, venous events, arterial events, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, abdominal pain, nausea, vomiting, diarrhea, cataracts"
232,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
233,BESIVANCE,warnings and precautions,"overgrowth of non-susceptible organisms, including fungi, super-infection"
234,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation and fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
235,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, hyperthyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm"
236,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia and Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, increased blood pressure, falls, urinary tract infections, syncope"
237,NORTHERA,boxed warnings,supine hypertension
238,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, Hyperpyrexia, confusion, exacerbate symptoms in patients with existing ischemic heart disease, arrhythmias, congestive heart failure, Allergic reactions, neuroleptic malignant syndrome (NMS), fever or hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, allergic-type reactions (including bronchial asthma), aspirin hypersensitivity"
239,ADCETRIS,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis, Stevens-Johnson syndrome, tumor lysis syndrome, embryo-fetal toxicity, pneumonia, bacteremia, sepsis, septic shock, pulmonary embolism, pneumothorax, pyelonephritis, septic shock, supraventricular arrhythmia, urinary tract infection, acute respiratory distress syndrome, paraesthesia."
240,ADREVIEW,all-concat,"Serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity (hypotension, metabolic acidosis), Gasping Syndrome, kernicterus, increased radiation exposure, decreased quality of scintigraphic images, transient episode of hypertension"
241,AFINITOR,all-concat,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hypercholesterolemia, Hyperglycemia, Increased aspartate transaminase (AST), Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Hemoglobin decreased, WBC decreased, Platelets decreased, Lymphocytes decreased, Neutrophils decreased, Glucose increased, Cholesterol increased, Alkaline phosphatase increased, Bicarbonate decreased, Phosphate decreased, Calcium decreased, Potassium decreased, Creatinine increased, Sodium decreased, Bilirubin increased, Potassium increased, Vomiting, Constipation, Dry mouth, Pyrexia, Weight decreased, Arthralgia, Back pain, Pain in extremity, Muscle spasms, Dysgeusia, Insomnia, Dyspnea, Epistaxis, Pneumonitis, Pruritus, Alopecia, Hot flush, Hemorrhage, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hand-foot syndrome, Nail disorder, Erythema, Onychoclasis, Skin lesion, Acneiform dermatitis, Angioedema, Exacerbation of pre-existing diabetes mellitus, New onset of diabetes mellitus, Dizziness, Paresthesia, Eyelid edema, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal failure, Tachycardia, Congestive cardiac failure, Jaw pain, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Cellulitis, Hyperglycemia, Elevated creatinine, Acute respiratory failure, Hepatic failure, Sepsis, Pulmonary embolism, Myocardial infarction, Congestive heart failure, Sudden death, Thrombotic events, Pulmonary embolus, Thrombosis, Gastroenteritis, Aggression, Agitation, Anxiety, Panic attack, Abnormal behavior, Obsessive compulsive disorder, Dermatitis allergic, Urticaria, Hypersensitivity, Pneumocystis jiroveci pneumonia (PJP), Hepatitis B virus reactivation, Aspergillosis, Candidiasis, Pneumocystis jiroveci pneumonia, Respiratory failure, Hepatic failure, Acute renal failure, Pneumonia, Sepsis, Hepatitis C, Pneumonitis, Interstitial lung disease, Lung infiltration, Pulmonary fibrosis, Restrictive pulmonary disease, Enteritis, Enterocolitis, Colitis, Defecation urgency, Steatorrhea, Malaise, Nasopharyngitis, Rhinitis, Upper respiratory tract infection (URI), Diabetes mellitus, Headache/migraine, Productive cough, Oropharyngeal pain, Nail disorders, Pruritus generalized, Dry skin/xeroderma, Elevated partial thromboplastin time, Pharyngitis streptococcal, Behavioral disturbance, Amenorrhea, Dysmenorrhea, Metrorrhagia, Unspecified menstrual irregularity, Nausea, Pain in extremity, Insomnia, Epistaxis, Increased blood luteinizing hormone (LH) levels, Pneumonitis, Elevated partial thromboplastin time, Neutropenia, Elevated aspartate transaminase (AST), Elevated alanine transaminase (ALT), Hypophosphatemia, Hypertriglyceridemia, Hypercholesterolemia, Hypophosphatemia, Alkaline phosphatase increased, Fasting hyperglycemia, Hyperglycemia, Elevated creatinine, Hemoglobin decreased, Leucopenia, Neutropenia, Lymphopenia, Thrombocytopenia, Hypercholesterolemia, Hypertriglyceridemia, Anemia, Elevated aspartate transaminase (AST), Elevated alanine transaminase (ALT), Hypophosphatemia, Acute respiratory distress, Cardiac arrest, Death (cause unknown), Hepatic failure, Pneumonia, Sepsis, Pulmonary embolism, Hypoglycemia, Cardiac arrest, Myocardial infarction, Congestive heart failure, Sudden death, Pulmonary embolus, Thrombosis, Abdominal pain, Dry mouth, Hemorrhoids, Dysphagia, Impaired wound healing, Weight decreased, Chest pain, Chills, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hand-foot syndrome, Erythema, Onychoclasis, Skin lesion, Acneiform dermatitis, Exacerbation of pre-existing diabetes mellitus, New onset of diabetes mellitus, Insomnia, Dizziness, Paresthesia, Eyelid edema, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal failure, Tachycardia, Congestive cardiac failure, Jaw pain, Hemorrhage."
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events leading to discontinuation, confusional state, dose-dependent increase in the incidence of seizures, seizures at 20 mg twice daily, seizures during treatment with dalfampridine 15 mg twice daily, seizures in the post-marketing period, seizures in patients without a history of seizures, anaphylaxis and severe allergic reactions, respiratory compromise, urticaria, angioedema of the throat and or tongue."
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing, image interpretation errors, radiation risk"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, Ear and labyrinth disorders, Eye disorders, Gastrointestinal disorders, General disorders and administration site conditions, Infections and Infestations, Injury, poisoning and procedural complications, Metabolism and nutrition disorders, Nervous system disorders, Psychiatric disorders, Respiratory, thoracic and mediastinal disorders, Skin and subcutaneous tissue disorders, Vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, Dizziness and Disturbance in Gait and Coordination, Somnolence and Fatigue, Cognitive Dysfunction, Visual Changes, Hazardous Activities, Withdrawal of AEDs, Hepatic effects, Abnormal thyroid function tests"
245,ARCAPTA,all-concat,"cough, oropharyngeal pain, nasopharyngitis, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase, palpitations, pruritus/rash, dizziness"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia, leukopenia (neutropenia and lymphopenia), sepsis, liver function test abnormalities, embryo-fetal toxicity, teratogenicity, embryo-fetal lethality"
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Serious and sometimes fatal infections, Progressive Multifocal Leukoencephalopathy (PML), upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, infections leading to discontinuation of treatment, infections resulting in death, malignancies including non-melanoma skin cancers, acute hypersensitivity reactions, death, rash, fatigue, myalgia, headache, facial edema, hypotension, angioedema, urticaria, pruritus, dyspnea, serious infusion reactions, bradycardia, psychiatric events, depression-related events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, live vaccines, secondary transmission of infection, new immunizations, concomitant use with other biologic therapies or intravenous cyclophosphamide."
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, capillary leak syndrome, hypersensitivity, bronchospasm, asthenia, disseminated intravascular coagulation, hemophagocytic lymphohistiocytosis/macrophage activation syndrome, disturbances in consciousness, coordination and balance disorders, opportunistic infections, catheter-site infections, seizures, transient elevations in liver enzymes, cranial magnetic resonance imaging changes."
251,BOSULIF,all-concat,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, Diarrhea (82%), nausea (46%), thrombocytopenia (41%), vomiting (39%), abdominal pain (37%), rash (35%), anemia (27%), pyrexia (26%), fatigue (24%), Diarrhea (84%, 9%), Nausea (46%, 1%), Abdominal Pain (40%, 1%), Thrombocytopenia (40%, 26%), Vomiting (37%, 3%), Rash (34%, 8%), Fatigue (26%, 1%), Anemia (23%, 9%), Pyrexia (22%, <1%), Increased alanine aminotransferase (20%, 7%), Headache (20%, 1%), Cough (20%, 0%), Increased aspartate aminotransferase (16%, 4%), Neutropenia (16%, 11%), Edema (14%, <1%), Arthralgia (14%, <1%), Decreased appetite (13%, 1%), Respiratory tract infection (12%, <1%), Nasopharyngitis (12%, 0%), Back pain (12%, 1%), Asthenia (11%, 1%), Pruritus (11%, 1%), Dizziness (10%, 0%), Dyspnea (10%, 1%), QTcF interval of greater than 500 milliseconds (0.2%), Platelet Count (Low) less than 50*10^9/L (33%), Absolute Neutrophil Count less than 1*10^9/L (23%), Hemoglobin (Low) less than 80 g/L (19%), SGPT/ALT greater than 5.0*ULN (9%), SGOT/AST greater than 5.0*ULN (4%), Lipase greater than 2*ULN (7%), Phosphorus (Low) less than 0.6 mmol/L (7%), Total Bilirubin greater than 3.0*ULN (1%), febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, anaphylactic shock, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, pruritus, acne, erythema multiforme, exfoliative rash, drug eruption, drug induced liver injury, severe fluid retention, pleural effusion, pericardial effusion, peripheral edema, pulmonary edema, decline in estimated glomerular filtration rate (eGFR), embryofetal toxicities"
252,BREO,all-concat,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, influenza, back pain, pneumonia, arthralgia, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, glaucoma, cataracts, hypokalemia, hyperglycemia"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury/damage, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias"
255,CHOLINE,all-concat,"mild injection site reaction, Imaging errors, Blood PSA levels < 2 ng/mL associated with poor performance of 11 C-choline PET imaging, Tissue inflammation associated with false positive 11 C-choline PET images, Allergic reactions, Anaphylaxis, Increased risk for cancer due to long-term cumulative radiation exposure"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, Active tuberculosis, Invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Bacterial, viral and other infections due to opportunistic pathogens, Legionella, Listeria, Hepatitis B virus reactivation, Demyelinating disease, Cytopenias, Lupus-like syndrome, Autoantibodies, Immunogenicity, Hypersensitivity Reactions, angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, (vasovagal) syncope, hepatosplenic T-cell lymphoma (HSTCL), acute and chronic leukemia, worsening congestive heart failure (CHF), new onset CHF, anaphylaxis, serious allergic reactions, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma."
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, negative inotropic effects, exacerbate heart failure, rebound hypertension"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), QT prolongation, congenital prolongation of the QT interval, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, disturbances of electrolyte balance, hypokalemia, hypomagnesemia, recrudescence"
259,COMETRIQ,all-concat,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, hemorrhoids, dysphagia, dyspepsia, dehydration, general deterioration, overt hypertension, malignant hypertension"
260,DALVANCE,all-concat,"nausea (5.5%), headache (4.7%), diarrhea (4.4%), vomiting (2.8%), rash (2.7%), pruritus (2.1%), anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations, serious hypersensitivity (anaphylactic) and skin reactions, ""Red-Man Syndrome,"" Clostridium difficile-associated diarrhea (CDAD)"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema, injection site pain"
262,DIFICID,all-concat,"nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), anemia (2%), neutropenia (2%), vomiting (0.5%), abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, dyspnea, angioedema"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, hypersensitivity /anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
264,DUAVEE,all-concat,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality, serious adverse reactions, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, stroke, deep vein thrombosis (DVT), probable dementia, increased risks of stroke, increased risk of endometrial hyperplasia, increased risk of endometrial cancer, increased risk of gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, monitor thyroid function, blood clots, cancer of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, upset stomach, throat pain, neck pain, currently have or have had blood clots, unusual vaginal bleeding, currently have or have had certain cancers, currently have or have had liver problems, been diagnosed with a bleeding disorder, pregnant, breastfeeding, unusual vaginal bleeding, asthma, epilepsy, diabetes, migraine, endometriosis, lupus, heart, liver, thyroid, kidneys, high calcium levels in your blood, surgery, bed rest, blood clots, stroke, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, new breast lumps, unusual vaginal bleeding, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, Coronary Heart Disease, Venous Thromboembolism (VTE), Endometrial Cancer, Breast Cancer, Ovarian Cancer, Probable Dementia, Gallbladder Disease, Visual Abnormalities, Elevated Blood Pressure, Hypertriglyceridemia, Hepatic Impairment and Past History of Cholestatic Jaundice, Hypothyroidism, Fluid Retention, Hypocalcemia, Hereditary Angioedema, Exacerbation of Other Conditions, Premenopausal Women, Laboratory Tests, Drug-Laboratory Test Interactions, Accelerated prothrombin time, partial thromboplastin time, platelet aggregation time, increased platelet count, increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex, II-VII-X complex, and beta-thromboglobulin, decreased levels of antifactor Xa and antithrombin III, decreased antithrombin III activity, increased levels of fibrinogen and fibrinogen activity, increased plasminogen antigen and activity, Increased thyroid-binding globulin (TBG), Other binding proteins, Impaired glucose tolerance."
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, posterior subcapsular cataract formation, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia and Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, blurred vision, diplopia, reduced visual acuity and accommodation, breathing difficulties, dyspnea, muscle atrophy, increase in mean blood glucose, reduction in heart rate, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site bruising, injection site reaction, injection site swelling, injection site erythema, injection site haematoma, facial paresis, hypoesthesia, erythema, excessive granulation tissue, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, sensation of heaviness, gait disturbance, hypertonia, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, eyelid ptosis, dysphagia, gait disturbance, hypertonia, sensation of heaviness."
267,EDARBI,all-concat,"diarrhea, hypotension/orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high markedly abnormal platelet counts, high markedly abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, injury and death to the developing fetus, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, neonatal hypotension, neonatal renal failure, neonatal death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure"
268,ELIQUIS,all-concat,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, Most common adverse reactions (>1%) are related to bleeding, Bleeding-related adverse reactions, Major bleeding, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Skin rash, Anaphylactic reactions, Allergic edema, Syncope, Adverse reactions, Bleeding Endpoint, Fatal, Hgb decrease >=2 g/dL, Transfusion of >=2 units RBC, Bleed at critical site, Major+ CRNM, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Epistaxis, Gastrointestinal hemorrhage, Hematochezia, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Hematuria, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Hypersensitivity, Muscle hemorrhage, Ocular hemorrhage, Rectal hemorrhage, Hemorrhagic anemia, Hemorrhoidal hemorrhage, Anal hemorrhage, Wound hemorrhage, Postprocedural hemorrhage, Traumatic hematoma, Periorbital hematoma, Muscle hemorrhage, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Occult blood, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma, ELIQUIS can cause serious, potentially fatal bleeding, Active pathological hemorrhage, Spinal/Epidural Anesthesia or Puncture, Epidural or spinal hematomas, Long-term or permanent paralysis, Prosthetic heart valves: ELIQUIS use not recommended, Acute PE in Hemodynamically Unstable Patients or Patients who Require Thrombolysis or Pulmonary Embolectomy"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea and vomiting, diarrhea"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, acute kidney injury, acute kidney injury sometimes requiring dialysis, local tissue reactions, myocyte necrosis and inflammation, falsely high or low serum iron values, reduced hepatic contrast."
271,ERWINAZE,all-concat,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis and hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, thrombosis, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, hemorrhage, infarct, hyperbilirubinemia, hyperglycemia, hyperlipidemia, ketoacidosis, CNS events, cerebral venous thrombosis, anti-drug antibodies (ADA), anaphylaxis, Severe or hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decreased, protein C activity decreased, protein S activity decreased, anti-thrombin III decreased"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal tear, endophthalmitis"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, vision blurred, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality in elderly patients with dementia-related psychosis, cerebrovascular adverse events including stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), Tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, body temperature regulation disruption, dysphagia, aspiration pneumonia, suicide, priapism, cognitive and motor impairment."
274,FARXIGA,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, hyperphosphatemia."
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, Neutropenia, Agranulocytosis, Nausea, Abdominal pain/discomfort, Vomiting, Diarrhea, Dyspepsia, Alanine Aminotransferase increased, Neutrophil count decreased, Weight increased, Aspartate Aminotransferase increased, Increased appetite, Decreased appetite, Arthralgia, Back pain, Pain in extremity, Arthropathy, Headache, Chromaturia, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, anti-icatibant antibodies, hypersensitivity, anaphylactic reactions"
277,FULYZAQ,all-concat,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury, moderate irritation"
279,GILENYA,all-concat,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic and hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma, bradyarrhythmia, hypotension, fatigue, palpitations, chest pain, transient AV conduction delays, first-degree AV block, second-degree AV block, third-degree AV block, AV block with junctional escape, syncope, transient asystole, unexplained death, bronchitis, herpes zoster, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory, orientation, confusion, personality changes, blurred vision, decreased visual acuity, severe headache, altered mental status, visual disturbances, seizure, forced expiratory volume over 1 second (FEV1) reduction, diffusion lung capacity for carbon monoxide (DLCO) reduction, elevation of liver transaminases, jaundice, dark urine, fetal harm, systolic pressure increase, diastolic pressure increase, hypertension, decreased lymphocyte counts."
280,GILOTRIF,all-concat,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, Gastrointestinal disorders, Skin and subcutaneous tissue disorders, Infections and infestations, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Investigations, General disorders and administration site conditions, Eye disorders, Pancreatitis, dehydration, renal failure, bullous, blistering, exfoliating lesions, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, embryotoxic, abortions, keratitis, lacrimation, light sensitivity, blurred vision, eye pain, red eye, embryofetal toxicity."
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, severe sickle cell crises, hypotension, hypoalbuminemia, edema, hemoconcentration"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, headache, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, embryo-fetal toxicity, QT prolongation"
283,HORIZANT,all-concat,"Somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, insomnia, asthenia, confusional state, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma and carcinoma, new tumors, preexisting tumors worsened"
284,ILARIS,all-concat,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, urinary tract infection, viral infection, rhinitis, bronchitis, gastroenteritis, weight increased, musculoskeletal pain, vertigo, hypersensitivity reactions, decreased white blood cells, neutrophils, platelets, high ALT, high AST, elevated serum bilirubin, macrophage activation syndrome (MAS), tuberculosis, latent tuberculosis, malignancies"
285,IMBRUVICA,all-concat,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, elevated uric acid levels, hyperuricemia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, stomatitis, dyspepsia, sinusitis, urinary tract infection, chills, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, vision blurred, pruritus, arthropathy, skin cancer, anaphylactic shock, urticaria, angioedema, progressive multifocal leukoencephalopathy (PML), palpitations, lightheadedness, new onset dyspnea, non-skin carcinomas, non-melanoma skin cancer, malformations in rats, reduced fetal weights"
286,INLYTA,all-concat,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation and fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, cerebral hemorrhage, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, reversible posterior leukoencephalopathy syndrome, alanine aminotransferase elevations, aspartate aminotransferase elevations, bilirubin elevations, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, alkaline phosphatase increased, hyperglycemia, amylase increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia."
287,INTELENCE,all-concat,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, rhabdomyolysis, fatal cases of toxic epidermal necrolysis"
288,INVOKANA,all-concat,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration), falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, increased serum potassium, increased serum magnesium, increased serum phosphate, increased hemoglobin, decreases in Bone Mineral Density (BMD)."
289,JARDIANCE,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Thirst (including polydipsia), Volume Depletion, blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increases, eGFR decreases, Overall hypoglycemic events, Severe hypoglycemic events, vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis, Phimosis, asymptomatic bacteriuria, cystitis, LDL-C increases, Increase in Hematocrit, Symptomatic hypotension, Macrovascular risk reduction."
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Use in Elderly Patients, Use in Patients with Hepatic Impairment, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, treatment discontinuations due to adverse drug reactions, dose reductions, dose delays, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, fatal infectious adverse events, sepsis, septic shock, neutropenic deaths, increased AST, increased ALT, increased bilirubin, Gastritis, intestinal obstruction, generalized rash/erythema, bronchospasm, neutropenic infections, G-CSF administration, neutropenia complications, hemoglobin < 10 g/dl, gastrointestinal hemorrhage, perforation, ileus, enterocolitis, neutropenic enterocolitis, abdominal pain and tenderness, persistent constipation, obstructive uropathy, severe hepatic impairment, embryotoxic, fetotoxic, abortifacient."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, antibodies to KALBITOR, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash, urticaria"
293,KALYDECO,all-concat,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, non-congenital lens opacities/cataracts"
294,KYPROLIS,all-concat,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity and Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, hepatic failure, embryo-fetal toxicity."
295,LUMIZYME,all-concat,"anaphylaxis, hypersensitivity reactions, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, flu-like illness, chills, arthralgia, pain, angioedema, throat tightness, chest pain/discomfort, bradycardia, bronchospasm, hypotension, periorbital edema, face edema, chest discomfort/pain, pruritus, paresthesia, local swelling, diarrhea, pruritus, rash papular, edema peripheral, supraventricular tachycardia"
296,MULTAQ,all-concat,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia and hypomagnesemia with potassium-depleting diuretics, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, Photosensitivity reaction, dysgeusia, Early increases in creatinine >=10%, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease including pneumonitis and pulmonary fibrosis, Anaphylactic reactions including angioedema, Vasculitis, including leukocytoclastic vasculitis, Increased risk of death, stroke and heart failure, Cardiovascular death in NYHA Class IV or Decompensated Heart Failure, Cardiovascular Death and Heart Failure in Permanent AF, Increased Risk of Stroke in Permanent AF, New Onset or Worsening Heart Failure, Hepatocellular liver injury, acute liver failure requiring transplant, Hepatic serum enzymes elevation, Pulmonary Toxicity, Hypokalemia, Hypomagnesemia, QT Interval Prolongation, Renal Impairment and Failure, Marked increase in serum creatinine, pre-renal azotemia, acute renal failure, Small increases in creatinine levels, Fetal harm in animal studies"
297,NATAZIA,all-concat,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, headaches, irregular uterine bleeding, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea/ or vomiting, acne, mood changes, increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), headache (including migraines), weight increased, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, Gallbladder disease, hepatitis, Hypersensitivity, Fluid retention, hypertriglyceridemia, Dizziness, Chloasma, angioedema, erythema nodosum, erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis."
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"injection site reaction consisting of erythema (1.7 %), irritation (1.2 %), pain (3.9 %), Image interpretation errors, unintentional radiation exposure, increased risk of cancer"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia and Confusion, exacerbate existing ischemic heart disease, arrhythmias, and congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, increased blood pressure, falls, urinary tract infections, syncope, allergic reactions, fever or hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, FD&C Yellow No. 5 (tartrazine) sensitivity, bronchial asthma"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, other malignancies, Serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, Post-Transplant Lymphoproliferative Disorder, Malignancies, Progressive Multifocal Leukoencephalopathy, Bacterial infections, Mycobacterial infections, Viral infections, Fungal infections, Tuberculosis, herpes infections, CNS infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, Infusion Reactions, Proteinuria, Immunogenicity, New-Onset Diabetes After Transplantation, Dyslipidemia, Urinary tract infection, Upper respiratory infection, Nasopharyngitis, Cytomegalovirus infection, Influenza, Bronchitis, Diarrhea, Constipation, Nausea, Vomiting, Abdominal pain, Abdominal pain upper, Hyperkalemia, Hypokalemia, Hypophosphatemia, Dyslipidemia, Hyperglycemia, Hypocalcemia, Hypercholesterolemia, Hypomagnesemia, Hyperuricemia, Graft dysfunction, Peripheral edema, Pyrexia, Anemia, Leukopenia, Hematuria, Proteinuria, Dysuria, Renal tubular necrosis, Hypertension, Hypotension, Cough, Dyspnea, Blood creatinine increased, Arthralgia, Back pain, Headache, Dizziness, Tremor, Acne, Insomnia, Anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
302,ONFI,all-concat,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, constipation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, Vomiting, Constipation, Dysphagia, Pyrexia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence or Sedation, Lethargy, Drooling, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, Aspiration, respiratory depression, Rash, urticaria, angioedema, facial and lip edema"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, insomnia, back pain, frequent bowel movements, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
304,PICATO,all-concat,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, severe eye pain, anaphylaxis"
305,POTIGA,all-concat,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, Somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Fatigue, Asthenia, Influenza, Weight increased, Dizziness, Somnolence, Memory impairment, Tremor, Vertigo, Abnormal coordination, Disturbance in attention, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Paresthesia, Amnesia, Dysphasia, Confusional state, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, decrease in hemoglobin of >=2 g/dL, transfusion of >=2 units of packed red blood cells, bleeding at a critical site, fatal outcome, intracranial hemorrhage, intracerebral hemorrhage, subarachnoid bleed, subdural bleed, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleed, intraspinal bleed, intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, bleeding causing a fall in hemoglobin level of 2.0 g/dL, transfusion of 2 or more units of whole blood or red cells, myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma, paralysis, thromboembolic events, valve thrombosis, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions requiring intervention for hemodynamic compromise"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Lipids abnormalities, Proteinuria, Sustained hypertension, Orthostatic hypotension, Stevens-Johnson syndrome, Clinical Worsening/Suicide Risk, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, progressive dyspnea, cough, chest discomfort."
308,PROLIA,all-concat,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe bone, joint, muscle pain, marked elevation in serum PTH, suppression of bone turnover"
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, serum liver test abnormalities, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, febrile neutropenia, pain in extremity, dyspnea, dizziness, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, indirect hyperbilirubinemia, liver injury, hepatic decompensation, portal venous system events, venous and arterial events, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, abdominal pain, nausea, vomiting, diarrhea, portal vein thrombosis (PVT)."
310,QUTENZA,all-concat,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, eye and mucous membrane exposure, aerosolization of capsaicin, unintended skin exposure, procedural pain, treatment-related increases in pain, cardiovascular effects"
311,SAPHRIS,all-concat,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, hypertension, anxiety, oral hypoesthesia, toothache, arthralgia, pain in extremity, headache, depression, insomnia, tachycardia, oral paraesthesia, vomiting, abdominal pain, glossodynia, irritability, muscle strain, increased weight, hyperinsulinemia, ALT increased, AST increased, increased appetite, dehydration, myalgia, somnolence, headache, dizziness, dysgeusia, akathisia, parkinsonism, insomnia, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, fatigue, edema peripheral, hypertension, dystonia, parkinsonism, oculogyration, tremor, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling/sloughing, inflammation, choking, cerebrovascular adverse events (e.g., stroke, transient ischemic attack), Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, body weight gain, hyperprolactinemia, seizures, cognitive and motor impairment, body temperature regulation, dysphagia, aspiration pneumonia, orthostatic hypotension, syncope, leukopenia, neutropenia, agranulocytosis, QT prolongation, Torsade de Pointes, sudden death, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, hyperosmolar coma, ketoacidosis, death, cardiovascular (e.g., heart failure, sudden death), infectious (e.g., pneumonia), hyperpyrexia, muscle rigidity, altered mental status, autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis, cardiac dysrhythmia), elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, hypotension, tachycardia, swollen tongue, dyspnea, wheezing, rash, bradycardia, respiratory or central nervous system depression, transaminases elevations, ALT increased, AST increased, prolactin elevations, galactorrhea, dysmenorrhea, gynecomastia, Creatine Kinase (CK) elevations, pyrexia, feeling hot, aspiration pneumonia, myocardial infarction, unstable heart disease."
312,SIMPONI,all-concat,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, ALT elevations >= 5 * ULN, ALT elevations >= 3 * ULN, formation of autoantibodies, lupus-like syndrome, newly ANA-positive, newly positive anti-dsDNA antibodies, infusion reaction, antibodies to SIMPONI ARIA, neutralizing antibodies, Superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Dizziness, paresthesia, Constipation, Melanoma, Serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, Interstitial lung disease, Skin exfoliation, bullous skin reactions, Hepatitis B reactivation, Lymphoma, Heart failure, Demyelinating disease, Leukopenia, Pyrexia, Bacterial infections, Hepatosplenic T-cell lymphoma, Merkel cell carcinoma, Congestive Heart Failure, central nervous system demyelinating disorders, peripheral demyelinating disorders, Guillain-Barre syndrome, MS, optic neuritis, peripheral demyelinating polyneuropathy, pancytopenia, aplastic anemia, thrombocytopenia."
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, aminotransferase elevations, Clinically significant ventricular arrhythmia, A QTcF interval of greater than 500 ms, fatigue, anorexia, jaundice, dark urine, liver tenderness, hepatomegaly, total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, dizziness, arthralgia, diarrhea, gastroenteritis viral, change in color vision, Non-arteritic anterior ischemic optic neuropathy (NAION), sudden loss of vision, prolonged erection, priapism, sudden decrease or loss of hearing, tinnitus, dizziness, symptomatic hypotension, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
315,STRIBILD,all-concat,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, bone fractures, bone mineral density decrease, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response to infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
316,TAFINLAR,all-concat,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation, Retinal vein occlusion, Interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, cuSCC, non-cutaneous malignancies, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, brain stem hemorrhage, cerebral hemorrhage, gastric hemorrhage, epistaxis, gingival hemorrhage, hematuria, vaginal hemorrhage, hemorrhage intracranial, eye hemorrhage, vitreous hemorrhage, renal failure, urinary tract infection, dry skin, dermatitis acneiform, actinic keratosis, erythema, pruritus, dizziness, oropharyngeal pain, muscle spasms, pain in extremity, dehydration, insomnia, hemorrhage, RPED, uveitis, iritis."
317,TANZEUM,all-concat,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, Constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, anti-albiglutide antibodies, anti-GLP-1 antibodies, antibodies to human albumin, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), mass in the neck, dysphagia, dyspnea, persistent hoarseness, abdominal pain, vomiting, acute renal failure, worsening of chronic renal failure, hemodialysis, nausea, dehydration."
318,TECFIDERA,all-concat,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, difficulty breathing, urticaria, swelling of the throat and tongue, prolonged lymphopenia, progressive weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation leading to confusion and personality changes."
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, Serious Adverse Reactions, Adverse Reactions Leading to Discontinuation, Gastrointestinal Disorders, Increased transaminases, Hypokalemia, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis, serious hypersensitivity (anaphylactic) reactions, serious skin reactions, fatal hypersensitivity (anaphylactic) reactions, mild diarrhea, fatal colitis, Seroconversion, hemolytic anemia, drug-induced hemolytic anemia, Development of Drug-Resistant Bacteria"
320,TIVICAY,all-concat,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, Treatment-naive Subjects, Treatment-emergent ADRs of moderate to severe intensity, Insomnia, Depression, Abnormal dreams, Dizziness, Headache, Nausea, Diarrhea, Rash, Fatigue, Vertigo, Grade 1 insomnia, Treatment-experienced, Integrase Strand Transfer Inhibitor-naive Subjects, diarrhea, Treatment-experienced, Integrase Strand Transfer Inhibitor-experienced Subjects, Less Common Adverse Reactions Observed in Treatment-naive and Treatment-experienced Trials, Gastrointestinal Disorders, Abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, Hepatobiliary Disorders, Hepatitis, Musculoskeletal Disorders, Myositis, Psychiatric Disorders, Suicidal ideation, attempt, behavior, or completion, Renal and Urinary Disorders, Renal impairment, Skin and Subcutaneous Tissue Disorders, Pruritus, Laboratory Abnormalities, ALT, AST, Creatine kinase, Hyperglycemia, Lipase, Total neutrophils, Hepatitis B and/or Hepatitis C Virus Co-infection, Changes in Serum Creatinine, Clinical Trials Experience in Pediatric Subjects, rash, abdominal pain, elevated total bilirubin, lipase, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
321,TOVIAZ,all-concat,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
322,TREANDA,all-concat,"Myelosuppression, Infections, Anaphylaxis and Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, hemoglobin decreased, platelets decreased, leukocytes decreased, lymphocytes decreased, neutrophils decreased, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, anaphylaxis, injection or infusion site reactions, phlebitis, irritation, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (CMV), myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, embryo-fetal toxicity"
323,TRULICITY,all-concat,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR Interval Prolongation, first degree AV block, amylase increase, lipase increase, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), dysphagia, dyspnea, persistent hoarseness, acute renal failure, worsening of chronic renal failure, severe gastrointestinal disease, severe gastroparesis."
324,TUDORZA,all-concat,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, Skin irritation, scalp irritation, Application site Irritation, Application site anesthesia & hypoesthesia, Pain, Pruritus, Erythema, Pyoderma, Ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events, myocardial infarction (MI), stroke, hepatic failure, fatal and non-fatal hepatic failure, transaminase elevations, severe drug-induced liver injury."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, agranulocytosis, thrombocytopenia, embryofetal toxicity, hemoglobin decrease, platelet count decrease, dyspnea, exertional dyspnea, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, anti-drug antibodies, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, spinal or cervical cord compression (SCC), back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
329,VIZAMYL,all-concat,"flushing (2%), headache (1%), increased blood pressure (2%), nausea (1%), dizziness (1%), serious hypersensitivity reaction with flushing, dyspnea and chest pressure, hypersensitivity reactions such as flushing and dyspnea"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
331,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, hepatotoxicity, ILD, Electrocardiogram QT prolonged, Bradycardia, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Upper respiratory infection, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Dysgeusia, Headache, fatigue, neuropathy, rash, renal cyst, syncope, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, dyspnea, pneumonia, pneumonitis, pulmonary embolism, ILD, respiratory failure, sepsis, alanine aminotransferase (ALT) elevation, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, Vision disorders, visual impairment, photopsia, blurred vision, vitreous floaters, Neuropathy, Renal Cysts, Hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, Drug-induced hepatotoxicity, Concurrent elevations in alanine aminotransferase (ALT) or aspartate aminotransferase (AST), total bilirubin, Transaminase elevations, Severe, life-threatening, or fatal interstitial lung disease (ILD)/pneumonitis, QTc prolongation, Torsade de pointes, polymorphic ventricular tachycardia, serious arrhythmia, Symptomatic bradycardia, heart rate less than 50 beats per minute, Grade 3 syncope, Optic atrophy, optic nerve disorder, Grade 4 visual field defect with vision loss, embryotoxicity, fetotoxicity."
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal exposure, corneal ulceration, ectropion, reduced blinking, persistent epithelial defect, VII nerve disorders, narrow angle glaucoma, ecchymosis"
333,XIAFLEX,all-concat,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), blood blister, injection site hematoma, ecchymosis, penile hematoma, penile swelling, penile pain, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, penile ""popping"" sounds or sensations, hypersensitivity reactions, anaphylaxis, allergic reactions (pruritus), IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage."
334,XTANDI,all-concat,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis, fall-related injuries, joint injuries, hematomas, hypertensive crisis"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, intestinal perforation, hepatotoxicity, Stevens-Johnson syndrome, toxic epidermal necrolysis, peripheral motor neuropathy, Guillain-Barre syndrome, myasthenia gravis, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
336,ZERBAXA,all-concat,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis, anaphylactic reactions, worsening and/or complications of infection, surgery and underlying conditions."
337,ZYDELIG,all-concat,"Hepatotoxicity, Severe Diarrhea or Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, sepsis, febrile neutropenia, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, embryo-fetal toxicity"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, increased ALT, increased AST, dose reductions, dose interruptions, serious adverse drug reactions, fatal adverse reactions, Abdominal pain, Esophageal disorder, Fatigue, Rash, Interstitial lung disease/pneumonitis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, Drug-induced hepatotoxicity, elevations in alanine aminotransferase, jaundice, Concurrent elevations in ALT and total bilirubin, Severe ILD/pneumonitis, fatal ILD/pneumonitis, QTc interval prolongation, ventricular tachyarrhythmias, Torsade de pointes, sudden death, sinus bradycardia, symptomatic bradycardia, life-threatening bradycardia, Pancreatitis, CTCAE Grade 3-4 elevations of lipase and/or amylase, skeletal anomalies in rats and rabbits, increases in skeletal anomalies."
339,ZYTIGA,all-concat,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, Muscle discomfort, Dyspepsia, Upper respiratory tract infection, Urinary frequency, Nocturia, Fractures, Arrhythmia, Chest pain or chest discomfort, Cardiac failure, Pyrexia, Groin pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis, cardiovascular disease, myocardial ischemia, myocardial infarction, cardiorespiratory arrest, sudden death."
